Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.4 USD | -5.88% | -5.14% | -25.93% |
21/03 | Earnings Flash (ARMP) ARMATA PHARMACEUTICALS Reports Q4 Revenue $1.5M | MT |
21/03 | Armata Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 66
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pathogen-specific Bacteriophage Therapeutics
100.0
%
| 6 | 100.0 % | 5 | 100.0 % | -17.77% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States and Australia
100.0
%
| 6 | 100.0 % | 5 | 100.0 % | -17.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 68 | 11/23/11 |
Mina Pastagia
CTO | Chief Tech/Sci/R&D Officer | - | 26/20/26 |
Bryan Kadotani
PRN | Corporate Officer/Principal | - | - |
Richard Rychlik
AUD | Comptroller/Controller/Auditor | 68 | 05/23/05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 12/20/12 | |
Joseph Patti
BRD | Director/Board Member | 60 | 09/19/09 |
Jules Haimovitz
BRD | Director/Board Member | 73 | 01/21/01 |
Odysseas Kostas
BRD | Director/Board Member | 49 | 12/20/12 |
Robin Kramer
CHM | Chairman | 58 | 08/20/08 |
Todd Peterson
BRD | Director/Board Member | 66 | 10/19/10 |
Deborah Birx
CEO | Chief Executive Officer | 68 | 11/23/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,148,539 | 10,719,501 ( 29.65 %) | 0 | 29.65 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.93% | 92.18M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- ARMP Stock
- Company Armata Pharmaceuticals, Inc.